Showing results (1-10 of 353) with videos related to
Sort By:
Pageof 36
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 6, 2001
[Type 1 diabetes: origin and possibilities for prevention]C Mathieu, B Decallonne, K CasteelsAnnals of the New York Academy of Sciences|December 18, 2003
Defective activation-induced cell death in NOD T lymphocytes: 1,25-dihydroxyvitamin D3 restores defectB Decallonne, C MathieuVerhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|May 9, 2002
[1,25-dihydroxyvitamin D3: the endocrine system meets the immune system]C Mathieu, B Decallonne, E van EttenCurrent Opinion in Nephrology and Hypertension|July 1, 1995
Immunomodulatory effects of 1,25-dihydroxyvitamin D3K Casteels, R Bouillon, M Waer, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involvedC Mathieu, K Casteels, R Bouillon, et al.Methods (San Diego, Calif.)|February 16, 2002
An overview of real-time quantitative PCR: applications to quantify cytokine gene expressionA Giulietti, L Overbergh, D Valckx, et al.Endocrinology|March 1, 1995
Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060C Mathieu, M Waer, K Casteels, et al.Diabetologia|November 18, 2000
Streptococcal wall component OK432 restores sensitivity of non-obese diabetic (NOD) thymocytes to apoptotic signalsB Decallonne, L Overbergh, K M Casteels, et al.Journal of Autoimmunity|May 26, 2005
1Alpha,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cellsB Decallonne, E van Etten, L Overbergh, et al.Current Opinion in Nephrology and Hypertension|August 5, 1998
Recent developments in the use of vitamin D analoguesA Verstuyf, S Segaert, L Verlinden, et al.Pageof 36